Neurovascular Devices Market by Product, Disease Pathology : Global Opportunity Analysis and Industry Forecast, 2020–2027

Neurovascular Devices Market by Product, Disease Pathology : Global Opportunity Analysis and Industry Forecast, 2020–2027

  • August 2020 •
  • 250 pages •
  • Report ID: 5976940 •
  • Format: PDF
Neurovascular Devices Market by Product (Embolization Devices, Revascularization Devices, Embolic Protection Devices, and Accessory Devices), Disease Pathology (Aneurysm, Arteriovenous Malformation (AVM), Ischemic Stroke, Stenosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

The neurovascular devices market accounted for $2,935 million in 2019, and is expected to reach $3,712 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
Neurovascular devices are defined as instruments and machines employed in treatment of various neurovascular disorders. Furthermore, neurovascular disorders include medical conditions that affect blood vessels, which supply the brain and spinal cord with oxygenated blood. Thus, neurovascular devices such as embolization devices, revascularization devices, thrombectomy devices, and embolic protection devices are used in treatment of neurovascular disorders.
These devices are used in disorders such as aneurysm. For instance, embolization devices are used in occlusion of blood vessels to reduce blood flow, which, in turn, aids in reduction of blood flow. Similarly, other neurovascular devices such as thrombectomy devices are used in disorders such as ischemic stroke. For instance, these thrombectomy devices aid in recovering the brain from ischemic condition if it has not attained the stage of complete infarction. Thus, these devices restore perfusion through blocked artery.
The major factor that contributes toward growth of the neurovascular devices market include surge in geriatric population. Furthermore, other factors such as rise in prevalence of neurovascular diseases and surge in adoption of neurovascular devices across the globe also contribute to growth of the market. In addition, factors such as surge in technological advancements related to neurovascular devices also boost growth of the neurovascular devices market.
However, high cost of neurovascular devices and dearth of qualified neurosurgeons required to handle these devices restrict growth of the market. Conversely, high growth rate exhibited by developing nations provides lucrative opportunities for players operating in the neurovascular devices market
The global neurovascular devices market is segmented on the basis of product, disease pathology, and region to provide a detailed assessment of the market. By product, the market is divided into embolization devices, revascularization device, thrombectomy devices, embolic protection devices, and accessory devices.
Moreover, these product categories are further divided into sub segments for a profound understanding. For instance, the embolization devices segment is divided into clippings, embolic coils, coil assist stents, and coil assist balloons. In addition, the embolic coils segment is further divided into bare detachable coils and coated detachable coils.
The revascularization device segment is further divided into carotid artery stents and flow diversion stents. In addition, the thrombectomy devices segment is divided into clot retrieval devices, suction & aspiration devices, and snares. The embolic protection devices segment is divided in distal filter devices and balloon occlusion devices. Similarly, the accessory devices segment is divided into microcatheters, and micro guidewires. By disease pathology, the market is classified into aneurysm, arteriovenous malformation (AVM), stenosis, ischemic stroke and others. By region, the neurovascular devices market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The major players in the neurovascular devices market are Medtronic Plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc.., Integer Holdings Corporation, Acandis GmbH., W. L. Gore & Associates, Inc., and Microport Scientific Corporation.

KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global neurovascular devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
• By Product
o Embolization Devices
- Clippings
- Embolic Coils
• Bare Detachable Coils
• Coated Detachable Coils
- Coil Assist Stent
- Coil Assist Balloon
o Revascularization Devices
- Carotid Artery Stents
- Flow Diversion Stents
o Thrombectomy Devices
- Clot Retrieval Devices
- Suction & Aspiration Devices
- Snares
o Embolic Protection Devices
- Distal Filter Devices
- Balloon Occlusion Devices
o Accessory Devices
- Microcatheters
- Micro-guidewires

• By Disease Pathology
o Aneurysm
o Arteriovenous Malformation and Fistulas (AVM)
o Ischemic Stroke
o Stenosis
o Others
• By Region
o North America
- U.S.
- Canada
- Mexico
o Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
o Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
o LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

• List of key players profiled in the report:
• Medtronic Plc,
• Stryker Corporation
• Penumbra, Inc.
• Johnson & Johnson
• Terumo Corporation
• Merit Medical Systems, Inc.
• Integer Holdings Corporation
• Acandis GmbH
• W. L. Gore & Associates, Inc.
• Microport Scientific Corporation

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• Asahi Intecc co., ltd.
• Kaneka Medix Corp.
• Embolx, Inc.
• Wallaby Medical